Pharmacovigilance – University of Copenhagen


Pharmacovigilance is a Novo Nordisk Foundation funded initiative headed by Professor Morten Andersen who is currently establishing this new research platform. The aim is to develop new methods and tools and generate new evidence that will shape future drug safety surveillance. The research should contribute to the evaluation of benefits/risks of therapy, and enable patients, healthcare professionals, regulators and the pharmaceutical industry to improve drug use and prevent drug-related problems for the benefit of public health. During the next year the primary tasks will be to form a research group and develop a new curriculum and course program in pharmacovigilance.